Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

How imaging should properly be used in COVID-19 outbreak: an Italian experience.

Sverzellati N, Milone F, Balbi M.

Diagn Interv Radiol. 2020 Mar 31. doi: 10.5152/dir.2020.30320. [Epub ahead of print] No abstract available.

2.

Differentially regulated high-throughput CT imaging features correlate to distinct tumor immune contextures portraying a radiomic signature with prognostic impact on surgically resected NSCLC.

Mazzaschi G, Quaini F, Milanese G, Madeddu D, Bocchialini G, Ampollini L, Gnetti L, Lagrasta C, Silva M, Roti G, Sverzellati N, Tiseo M.

Ann Oncol. 2019 Apr;30 Suppl 2:ii1. doi: 10.1093/annonc/mdz072.001. No abstract available.

3.

Prognostic value of [18F]FDG PET/CT parameters in surgically resected primary lung adenocarcinoma: a single-center experience.

Ventura L, Scarlattei M, Gnetti L, Silini EM, Rossi M, Tiseo M, Sverzellati N, Bocchialini G, Musini L, Balestra V, Ampollini L, Rusca M, Carbognani P, Ruffini L.

Tumori. 2020 Feb 14:300891620904404. doi: 10.1177/0300891620904404. [Epub ahead of print]

PMID:
32056506
4.

Stratification of long-term outcome in stable idiopathic pulmonary fibrosis by combining longitudinal computed tomography and forced vital capacity.

Sverzellati N, Silva M, Seletti V, Galeone C, Palmucci S, Piciucchi S, Vancheri C, Poletti V, Tomassetti S, Karwoski R, Bartholmai BJ.

Eur Radiol. 2020 Jan 31. doi: 10.1007/s00330-019-06619-5. [Epub ahead of print]

PMID:
32006172
5.

Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): an overview of current and future therapeutic strategies.

Biondini D, Balestro E, Sverzellati N, Cocconcelli E, Bernardinello N, Ryerson CJ, Spagnolo P.

Expert Rev Respir Med. 2020 Apr;14(4):405-414. doi: 10.1080/17476348.2020.1724096. Epub 2020 Feb 3.

PMID:
31994940
6.

Point-of-care ultrasound (POCUS) in a remote area of Sierra Leone: impact on patient management and training program for community health officers.

Sabatino V, Caramia MR, Curatola A, Vassallo F, Deidda A, Cinicola B, Iodice F, Caffarelli C, Sverzellati N, Buonsenso D.

J Ultrasound. 2020 Jan 9. doi: 10.1007/s40477-019-00426-w. [Epub ahead of print]

PMID:
31919811
7.

Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab.

Bersanelli M, Gnetti L, Vaglio A, Sverzellati N, Campanini N, Incerti M, Galetti M, Varotti E, Corrado M, Parziale R, Bottarelli L, Azzoni C, Silini EM, Leonardi F, Buti S.

Acta Biomed. 2019 Dec 23;90(4):468-474. doi: 10.23750/abm.v90i4.7057.

PMID:
31910171
8.

Quantitative assessment of interstitial lung disease in Sjögren's syndrome.

Guisado-Vasco P, Silva M, Duarte-Millán MA, Sambataro G, Bertolazzi C, Pavone M, Martín-Garrido I, Martín-Segarra O, Luque-Pinilla JM, Santilli D, Sambataro D, Torrisi SE, Vancheri A, Gutiérrez M, Mejia M, Palmucci S, Mozzani F, Rojas-Serrano J, Vanchieri C, Sverzellati N, Ariani A.

PLoS One. 2019 Nov 8;14(11):e0224772. doi: 10.1371/journal.pone.0224772. eCollection 2019.

9.

Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.

Sestini S, Boeri M, Marchiano A, Pelosi G, Galeone C, Verri C, Suatoni P, Sverzellati N, Vecchia C, Sozzi G, Pastorino U.

Oncotarget. 2019 Oct 15;10(57):6043. doi: 10.18632/oncotarget.27256. eCollection 2019 Oct 15.

10.

CT angiography for pulmonary embolism in the emergency department: investigation of a protocol by 20 ml of high-concentration contrast medium.

Silva M, Milanese G, Cobelli R, Manna C, Rasciti E, Poggesi S, Sverzellati N.

Radiol Med. 2020 Feb;125(2):137-144. doi: 10.1007/s11547-019-01098-6. Epub 2019 Oct 28.

PMID:
31659676
11.

Lung cancer screening: tell me more about post-test risk.

Silva M, Milanese G, Pastorino U, Sverzellati N.

J Thorac Dis. 2019 Sep;11(9):3681-3688. doi: 10.21037/jtd.2019.09.28. No abstract available.

12.

Prognostic and predictive value of histogram analysis in patients with non-small cell lung cancer refractory to platinum treated by nivolumab: A multicentre retrospective study.

Ravanelli M, Agazzi GM, Milanese G, Roca E, Silva M, Tiseo M, Rondi P, Baggi A, Ganeshan B, Muri M, Panni S, Botti C, Sverzellati N, Maroldi R, Berruti A, Farina D.

Eur J Radiol. 2019 Sep;118:251-256. doi: 10.1016/j.ejrad.2019.07.019. Epub 2019 Jul 17.

PMID:
31439251
13.

Increased prevalence of small airways dysfunction in patients with systemic sclerosis as determined by impulse oscillometry.

Bonifazi M, Sverzellati N, Negri E, Pomponio G, Seletti V, Bonini M, Fraticelli P, Paolini L, Mattioli M, Franchi M, Tramacere I, Poletti V, La Vecchia C, Gasparini S, Gabrielli A.

Rheumatology (Oxford). 2020 Mar 1;59(3):641-649. doi: 10.1093/rheumatology/kez340.

PMID:
31436799
14.

Janus-faced amiodarone-induced pneumopathy.

Cerri S, Tonelli R, Faverio P, Sverzellati N, Clini E, Luppi F.

Pulmonology. 2020 Mar - Apr;26(2):101-103. doi: 10.1016/j.pulmoe.2019.07.003. Epub 2019 Aug 3. No abstract available.

15.

Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening.

Pastorino U, Sverzellati N, Sestini S, Silva M, Sabia F, Boeri M, Cantarutti A, Sozzi G, Corrao G, Marchianò A.

Eur J Cancer. 2019 Sep;118:142-148. doi: 10.1016/j.ejca.2019.06.009. Epub 2019 Jul 20.

16.

Performance of a new quantitative computed tomography index for interstitial lung disease assessment in systemic sclerosis.

Bocchino M, Bruzzese D, D'Alto M, Argiento P, Borgia A, Capaccio A, Romeo E, Russo B, Sanduzzi A, Valente T, Sverzellati N, Rea G, Vettori S.

Sci Rep. 2019 Jul 1;9(1):9468. doi: 10.1038/s41598-019-45990-7.

17.

Sulphurous thermal water inhalation impacts respiratory metabolic parameters in heavy smokers.

Carubbi C, Masselli E, Calabrò E, Bonati E, Galeone C, Andreoli R, Goldoni M, Corradi M, Sverzellati N, Pozzi G, Banchini A, Pastorino U, Vitale M.

Int J Biometeorol. 2019 Sep;63(9):1209-1216. doi: 10.1007/s00484-019-01737-7. Epub 2019 Jun 21.

PMID:
31227888
18.

Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.

Pastorino U, Silva M, Sestini S, Sabia F, Boeri M, Cantarutti A, Sverzellati N, Sozzi G, Corrao G, Marchianò A.

Ann Oncol. 2019 Oct 1;30(10):1672. doi: 10.1093/annonc/mdz169. No abstract available.

19.

Comparison of ultra-low dose chest CT scanning protocols for the detection of pulmonary nodules: a phantom study.

Milanese G, Silva M, Frauenfelder T, Eberhard M, Sabia F, Martini C, Marchianò A, Prokop M, Sverzellati N, Pastorino U.

Tumori. 2019 Oct;105(5):394-403. doi: 10.1177/0300891619847271. Epub 2019 May 1.

PMID:
31041885
20.

The value of high-resolution computed tomography (HRCT) to determine exercise ventilatory inefficiency and dynamic hyperinflation in adult patients with cystic fibrosis.

Crisafulli E, Teopompi E, Luceri S, Longo F, Tzani P, Pagano P, Ielpo A, Longo C, Di Paolo M, Sverzellati N, Palange P, Chetta A, Pisi G.

Respir Res. 2019 Apr 24;20(1):78. doi: 10.1186/s12931-019-1044-8.

21.

Spread through air spaces in lung adenocarcinoma: is radiology reliable yet?

Ledda RE, Milanese G, Gnetti L, Borghesi A, Sverzellati N, Silva M.

J Thorac Dis. 2019 Mar;11(Suppl 3):S256-S261. doi: 10.21037/jtd.2019.01.96. No abstract available.

22.

Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.

Pastorino U, Silva M, Sestini S, Sabia F, Boeri M, Cantarutti A, Sverzellati N, Sozzi G, Corrao G, Marchianò A.

Ann Oncol. 2019 Jul 1;30(7):1162-1169. doi: 10.1093/annonc/mdz117. Erratum in: Ann Oncol. 2019 Oct 1;30(10):1672.

23.

Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis.

Ariani A, Silva M, Bravi E, Parisi S, Saracco M, De Gennaro F, Caimmi C, Girelli F, De Santis M, Volpe A, Lumetti F, Hax V, Bredemeier M, Alfieri V, Santilli D, Bodini FC, Lucchini G, Mozzani F, Seletti V, Bacchini E, Arrigoni E, Giuggioli D, Chakr R, Idolazzi L, Bertorelli G, Imberti D, Michieletti E, Paolazzi G, Fusaro E, Chetta AA, Scirè CA, Sverzellati N.

RMD Open. 2019 Feb 14;5(1):e000820. doi: 10.1136/rmdopen-2018-000820. eCollection 2019.

24.

Management of incidental pulmonary nodule in CT: a survey by the Italian College of Chest Radiology.

Rampinelli C, Cicchetti G, Cortese G, Polverosi R, Farchione A, Iezzi R, Romei C, Valentini A, Gavelli G, Zompatori M, Bonomo L, Sverzellati N, Privitera C, Larici AR.

Radiol Med. 2019 Jul;124(7):602-612. doi: 10.1007/s11547-019-01011-1. Epub 2019 Mar 11.

PMID:
30859388
25.

A Case of Recurrent Secondary Aortoenteric Fistula 4 Months after Surgery Treated by Endovascular Coiling of the Aortic Stump and Bilateral Chimney Stent Grafts to Renal Arteries.

Colombi D, Bodini FC, Sverzellati N, Morelli N, Capelli P, Michieletti E.

Ann Vasc Surg. 2019 Aug;59:310.e1-310.e5. doi: 10.1016/j.avsg.2018.12.104. Epub 2019 Feb 23.

PMID:
30802570
26.

Quantification of epicardial fat with cardiac CT angiography and association with cardiovascular risk factors in symptomatic patients: from the ALTER-BIO (Alternative Cardiovascular Bio-Imaging markers) registry.

Milanese G, Silva M, Bruno L, Goldoni M, Benedetti G, Rossi E, Ferrari C, Grutta L, Maffei E, Toia P, Forte E, Bonadonna RC, Sverzellati N, Cademartiri F.

Diagn Interv Radiol. 2019 Jan;25(1):35-41. doi: 10.5152/dir.2018.18037.

27.

Look around your target: a new approach to early diagnosis of lung cancer.

Papapietro VR, Milanese G, Borghesi A, Sverzellati N, Silva M.

Ann Transl Med. 2018 Nov;6(Suppl 1):S77. doi: 10.21037/atm.2018.10.56. No abstract available.

28.

Quantitative analysis of lung sounds for monitoring idiopathic pulmonary fibrosis: a prospective pilot study.

Sgalla G, Larici AR, Sverzellati N, Bartholmai B, Walsh SLF, Nikolic D, Barney A, Fletcher S, Jones M, Davies DD, Richeldi L.

Eur Respir J. 2019 Mar 7;53(3). pii: 1802093. doi: 10.1183/13993003.02093-2018. Print 2019 Mar. No abstract available.

PMID:
30578384
29.

Variable radiological lung nodule evaluation leads to divergent management recommendations.

Nair A, Bartlett EC, Walsh SLF, Wells AU, Navani N, Hardavella G, Bhalla S, Calandriello L, Devaraj A, Goo JM, Klein JS, MacMahon H, Schaefer-Prokop CM, Seo JB, Sverzellati N, Desai SR; Lung Nodule Evaluation Group; Lung Nodule Evaluation Group.

Eur Respir J. 2018 Dec 20;52(6). pii: 1801359. doi: 10.1183/13993003.01359-2018. Print 2018 Dec.

PMID:
30409817
30.

Deep learning for classifying fibrotic lung disease on high-resolution computed tomography: a case-cohort study.

Walsh SLF, Calandriello L, Silva M, Sverzellati N.

Lancet Respir Med. 2018 Nov;6(11):837-845. doi: 10.1016/S2213-2600(18)30286-8. Epub 2018 Sep 16.

PMID:
30232049
31.

Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure.

Beghé B, Fabbri LM, Garofalo M, Schito M, Verduri A, Bortolotti M, Stendardo M, Ruggieri V, Fucili A, Sverzellati N, Della Casa G, Maietti E, Clini EM, Boschetto P.

Respiration. 2019;97(3):223-233. doi: 10.1159/000492286. Epub 2018 Sep 11.

PMID:
30205380
32.

The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: the study protocol.

Aliberti S, Codecasa LR, Gori A, Sotgiu G, Spotti M, Di Biagio A, Calcagno A, Nardini S, Assael BM, Tortoli E, Besozzi G, Ferrarese M, Matteelli A, Girardi E, De Lorenzo S, Seia M, Gramegna A, Del Prato B, Terranova L, Oriano M, Sverzellati N, Mirsaeidi M, Chalmers JD, Haworth CS, Loebinger MR, Aksamit T, Winthrop K, Ringshausen FC, Previdi G, Blasi F; IRENE Network.

Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):33. doi: 10.1186/s40248-018-0141-8. eCollection 2018.

33.

Long-Term Active Surveillance of Screening Detected Subsolid Nodules is a Safe Strategy to Reduce Overtreatment.

Silva M, Prokop M, Jacobs C, Capretti G, Sverzellati N, Ciompi F, van Ginneken B, Schaefer-Prokop CM, Galeone C, Marchianò A, Pastorino U.

J Thorac Oncol. 2018 Oct;13(10):1454-1463. doi: 10.1016/j.jtho.2018.06.013. Epub 2018 Jul 16.

34.

Loss of heterozygosity of key tumor suppressor genes in advanced renal cancer patients treated with nivolumab.

Bersanelli M, Gnetti L, Azzoni C, Bottarelli L, Sverzellati N, Campanini N, Varotti E, Corrado M, Parziale R, Rapacchi E, Caruso G, Leonardi F, Silini EM, Buti S.

Immunotherapy. 2018 Jul;10(9):743-752. doi: 10.2217/imt-2017-0160. Erratum in: Immunotherapy. 2018 Oct;10(14):1287-1288.

PMID:
30008256
35.

Sarcoidosis: is cryobiopsy not cool enough? - Authors' reply.

Spagnolo P, Rossi G, Trisolini R, Sverzellati N, Baughman RP, Wells AU.

Lancet Respir Med. 2018 Sep;6(9):e45. doi: 10.1016/S2213-2600(18)30217-0. Epub 2018 Jul 11. No abstract available.

PMID:
30007850
36.

Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis.

Wu X, Kim GH, Salisbury ML, Barber D, Bartholmai BJ, Brown KK, Conoscenti CS, De Backer J, Flaherty KR, Gruden JF, Hoffman EA, Humphries SM, Jacob J, Maher TM, Raghu G, Richeldi L, Ross BD, Schlenker-Herceg R, Sverzellati N, Wells AU, Martinez FJ, Lynch DA, Goldin J, Walsh SLF.

Am J Respir Crit Care Med. 2019 Jan 1;199(1):12-21. doi: 10.1164/rccm.201803-0444PP. No abstract available.

37.

Classification of CT Pulmonary Opacities as Perifissural Nodules: Reader Variability.

Schreuder A, van Ginneken B, Scholten ET, Jacobs C, Prokop M, Sverzellati N, Desai SR, Devaraj A, Schaefer-Prokop CM.

Radiology. 2018 Sep;288(3):867-875. doi: 10.1148/radiol.2018172771. Epub 2018 Jul 3.

PMID:
29969076
38.

Interstitial lung abnormalities: prognostic stratification of subtle radiological findings.

Silva M, Milanese G, Sverzellati N.

Curr Opin Pulm Med. 2018 Sep;24(5):432-439. doi: 10.1097/MCP.0000000000000497. Review.

PMID:
29939864
39.

"Velcro-type" crackles predict specific radiologic features of fibrotic interstitial lung disease.

Sgalla G, Walsh SLF, Sverzellati N, Fletcher S, Cerri S, Dimitrov B, Nikolic D, Barney A, Pancaldi F, Larcher L, Luppi F, Jones MG, Davies D, Richeldi L.

BMC Pulm Med. 2018 Jun 18;18(1):103. doi: 10.1186/s12890-018-0670-0.

40.

The Matter of the Lung: Quantification of Vascular Substance in Asthma.

Sverzellati N, Silva M.

Am J Respir Crit Care Med. 2018 Jul 1;198(1):1-2. doi: 10.1164/rccm.201804-0804ED. No abstract available.

PMID:
29882680
41.

The Lung in Rheumatoid Arthritis: Focus on Interstitial Lung Disease.

Spagnolo P, Lee JS, Sverzellati N, Rossi G, Cottin V.

Arthritis Rheumatol. 2018 Oct;70(10):1544-1554. doi: 10.1002/art.40574. Epub 2018 Sep 4. Review.

42.

Pulmonary sarcoidosis.

Spagnolo P, Rossi G, Trisolini R, Sverzellati N, Baughman RP, Wells AU.

Lancet Respir Med. 2018 May;6(5):389-402. doi: 10.1016/S2213-2600(18)30064-X. Epub 2018 Apr 3. Review.

PMID:
29625772
43.

Detection of Subsolid Nodules in Lung Cancer Screening: Complementary Sensitivity of Visual Reading and Computer-Aided Diagnosis.

Silva M, Schaefer-Prokop CM, Jacobs C, Capretti G, Ciompi F, van Ginneken B, Pastorino U, Sverzellati N.

Invest Radiol. 2018 Aug;53(8):441-449. doi: 10.1097/RLI.0000000000000464.

PMID:
29543693
44.

Diagnostic criteria for idiopathic pulmonary fibrosis - Authors' reply.

Lynch DA, Sverzellati N, Travis WD, Colby TV, Inoue Y, Nicholson AG, Raoof S, Richeldi L, Ryerson CJ, Ryu JH.

Lancet Respir Med. 2018 Feb;6(2):e7. doi: 10.1016/S2213-2600(18)30021-3. No abstract available.

PMID:
29413090
45.

Automatic segmentation of the solid core and enclosed vessels in subsolid pulmonary nodules.

Charbonnier JP, Chung K, Scholten ET, van Rikxoort EM, Jacobs C, Sverzellati N, Silva M, Pastorino U, van Ginneken B, Ciompi F.

Sci Rep. 2018 Jan 12;8(1):646. doi: 10.1038/s41598-017-19101-3.

46.

Transbronchial Cryobiopsies for the Diagnosis of Diffuse Parenchymal Lung Diseases: Expert Statement from the Cryobiopsy Working Group on Safety and Utility and a Call for Standardization of the Procedure.

Hetzel J, Maldonado F, Ravaglia C, Wells AU, Colby TV, Tomassetti S, Ryu JH, Fruchter O, Piciucchi S, Dubini A, Cavazza A, Chilosi M, Sverzellati N, Valeyre D, Leduc D, Walsh SLF, Gasparini S, Hetzel M, Hagmeyer L, Haentschel M, Eberhardt R, Darwiche K, Yarmus LB, Torrego A, Krishna G, Shah PL, Annema JT, Herth FJF, Poletti V.

Respiration. 2018;95(3):188-200. doi: 10.1159/000484055. Epub 2018 Jan 9.

47.

Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist.

Sverzellati N, Odone A, Silva M, Polverosi R, Florio C, Cardinale L, Cortese G, Addonisio G, Zompatori M, Dalpiaz G, Piciucchi S, Larici AR; Italian Structured Report on Fibrosing Lung Disease Consort.

Radiol Med. 2018 Apr;123(4):245-253. doi: 10.1007/s11547-017-0835-6. Epub 2017 Dec 11.

48.

Adenocarcinoma in pure ground glass nodules: histological evidence of invasion and open debate on optimal management.

Milanese G, Sverzellati N, Pastorino U, Silva M.

J Thorac Dis. 2017 Sep;9(9):2862-2867. doi: 10.21037/jtd.2017.08.120. No abstract available.

49.

European position statement on lung cancer screening.

Oudkerk M, Devaraj A, Vliegenthart R, Henzler T, Prosch H, Heussel CP, Bastarrika G, Sverzellati N, Mascalchi M, Delorme S, Baldwin DR, Callister ME, Becker N, Heuvelmans MA, Rzyman W, Infante MV, Pastorino U, Pedersen JH, Paci E, Duffy SW, de Koning H, Field JK.

Lancet Oncol. 2017 Dec;18(12):e754-e766. doi: 10.1016/S1470-2045(17)30861-6. Review.

PMID:
29208441
50.

Pleural plaques in lung cancer screening by low-dose computed tomography: prevalence, association with lung cancer and mortality.

Silva M, Sverzellati N, Colombi D, Milanese G, La Vecchia C, Galeone C, Marchianò A, Pastorino U.

BMC Pulm Med. 2017 Nov 25;17(1):155. doi: 10.1186/s12890-017-0506-3.

Supplemental Content

Loading ...
Support Center